Q Therapeutics, Inc.
PrivateLast Round
Series B
Feb 15, 2008
Total Funding Raised
$24.05M
Company Overview
Q Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Series B round in February 2008.
Q Therapeutics, Inc. is a biotechnology company that develops adult stem cell therapies for the treatment of debilitating central nervous system diseases and injuries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Q Therapeutics, Inc. Comparables
Compare Q Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UCB | 77% | |
| Lineage Cell Therapeutics | 77% | |
| Brainstorm Cell Therapeutics Inc. | 76% |
For institutional investors. Book with your work email.
Q Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 15, 2008 | ||||
| Series A | May 18, 2004 |
For institutional investors. Book with your work email.
Q Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| EPIC Ventures | Series B, Series A |
| Toucan Capital Corporation | Series B, Series A |
| Maryland Stem Cell Research Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Grew 75% QoQ from 4 to 7 employees.
- Apr 5, 2026
Monthly visitors grew 594% MoM, from 32 to 222.
For institutional investors. Book with your work email.
Q Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Q Therapeutics, Inc.'s valuation, stock price, and market status.
Is Q Therapeutics, Inc. a public or private company?
Q Therapeutics, Inc. is a private company.
What is the current stock price of Q Therapeutics, Inc.?
Q Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Q Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Q Therapeutics, Inc. worth (valuation)?
Valuation information for Q Therapeutics, Inc. is not publicly available.
Can I buy Q Therapeutics, Inc. stock?
Q Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Q Therapeutics, Inc.'s last funding round?
Q Therapeutics, Inc.'s most recent funding round was Series B on February 15, 2008.
Who are the main investors in Q Therapeutics, Inc.?
Key investors in Q Therapeutics, Inc. include NIH RADx, EPIC Ventures, Toucan Capital Corporation, Maryland Stem Cell Research Fund.
Will Q Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Q Therapeutics, Inc..
How can I track Q Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Q Therapeutics, Inc.'s shares on secondary markets.